| Interacting proteins: P09619 and O60674 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P09619 and O60674 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P09619 and O60674 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P09619 and O60674 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P09619 and O60674 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P09619 and O60674 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P09619 and O60674 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P09619 and O60674 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P09619 and O60674 |
Pubmed |
SVM Score :0.0 |
| These include PDGFRB , JAK 2 , NTRK 3 , ABL 2 , and ABL 1 , each of which encodes for proteins with tyrosine kinase activity . ^^^ |
|
| Interacting proteins: P09619 and O60674 |
Pubmed |
SVM Score :0.0 |
| Other tyrphostins discussed are AG 1478 and RG 13022 , which are both epidermal growth factor receptor kinase inhibitors ; AG 490 , a Jak 2 kinase inhibitor ; AG 1296 , a PDGFR kinase inhibitor ; and STI 571 ( imatinib , Glivec / Gleevec ; Novartis Pharma AG , Basel , Switzerland ) . ^^^ |
|
| Interacting proteins: P09619 and O60674 |
Pubmed |
SVM Score :0.0 |
| In vascular smooth muscle cells ( VSMCs ) , through its G protein coupled AngII Type 1 receptor ( AT ( 1 ) ) , AngII activates various intracellular protein kinases , such as receptor or non receptor tyrosine kinases , which includes epidermal growth factor receptor ( EGFR ) , platelet derived growth factor receptor ( PDGFR ) , c Src , PYK 2 , FAK , JAK 2 . ^^^ |
|
| Interacting proteins: P09619 and O60674 |
Pubmed |
SVM Score :0.0 |
| Some of the Ph negative myeloproliferative diseases are characterized by other chromosomal translocations involving a variety of tyrosine kinase genes , including ABL 1 , ABL 2 , PDGFRA , PDGFRB , FGFR 1 , and JAK 2 . ^^^ |
|